Sanofi-Aventis SA acquired 4,66 percent of Japanese generic Nichi-iko Pharmaceutical Co., in $48 million dollars. Therefore setting foot in the gigantic Japanese generic market, worth almost $97 billion.

The Food and Drug Administration approved Teva Pharmaceutical Industries Ltd. to market generic high blood pressure versions of Merck & Co. blockbuster drugs, Cozaar and Hyzaar, both known for active substance Losartan.

India´s top generic company Dr Reddy´s Laboratories Ltd. Anticipated in a meeting with analysts that their main corporative objective is in the next five years be a Top Five generic company in the US market.

US-Based Generics Company Par Pharmaceutical Companies Inc. announced launching of several doses of Risperdal M-TAB generic version drug, originally developed by J&J business unit, Janssen Pharma.

US-based Generics Mylan Inc. said that subsidiary Dey LP, started marketing of major depression disorder drug Emsam (Selegiline Transdermal System) a daily dose monoamine oxidase inhibitor (MAOI) drug.

U.S. Warner Chilcott Ltd. announced that signed a deal with Korean Dong-A PharmaTec Co. to develop and market an oral drug for erectile dysfunction.

New Jersey-based Barr Pharmaceuticals Inc. said its shareholders approved the proposed buyout of the company by Israeli generic drug maker Teva Pharmaceuticals Industries. In July, Teva offered to buy Barr Pharmaceuticals for $7.46 billion in stock and cash.

Anglo Swedish drug maker AstraZeneca Plc said that Teva Pharmaceutical Industries Ltd. has been granted approval by the Food and Drug Administration for a generic version of its asthma medication Pulmicort. AstraZeneca has brought a patent infringement case against Teva.